Back to top
more

QIAGEN (QGEN)

(Delayed Data from NYSE)

$36.95 USD

36.95
1,964,098

+0.37 (1.01%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $36.96 +0.01 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (149 out of 247)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Trina Mukherjee headshot

Can Economic Stimulus Save MedTech From Coronavirus Doldrums?

by Trina Mukherjee

Following the announcement of the agreement to pass the historic stimulus bill, we look into four MedTech stocks that stand to gain from the same.

Zacks Equity Research

Varian Unveils Proton Treatment Planning Eclipse v16 System

by Zacks Equity Research

The launch of this system is a step forward in Varian's (VAR) commitment toward strengthening its Proton Solutions segment.

Zacks Equity Research

Abbott (ABT) Rides on Point-of-Care Coronavirus Test Launch

by Zacks Equity Research

Abbott (ABT) launches a portable molecular point-of-care test to speed up coronavirus detection, especially in areas with severe outbreaks.

Zacks Equity Research

Here's Why You Should Hold on to Abbott (ABT) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Abbott (ABT) on its strong segmental results in the fourth quarter of 2019.

Zacks Equity Research

Medtronic's Evolut TAVR System Shows Positive Study Results

by Zacks Equity Research

Medtronic (MDT) presents favorable study outcomes for its Evolut TAVR system, which is expected to offer better treatment options to low-risk bicuspid aortic valve stenosis patients.

Zacks Equity Research

4 MedTech Stocks Set to Rebound Post Coronavirus-Led Crisis

by Zacks Equity Research

Here are some MedTech stocks which are steadily inching toward a trend reversal after registering record declines over the past few weeks.

Urmimala Biswas headshot

4 Stocks Countering Coronavirus Battle With Testing Kits

by Urmimala Biswas

While the market bloodbath is showing no signs of dissipating any time soon, investors might keep an eye on certain genetic testing and medical device companies.

Nalak Das headshot

5 Top Low-Beta Stocks Surged in March Defying Coronavirus

by Nalak Das

The global financial markets are currently witnessing one of the worst periods since the Great Depression due to the coronavirus-led crisis.

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for March 27th

by Zacks Equity Research

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 27th

Zacks Equity Research

Here's Why You Should Hold on to LabCorp (LH) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about LabCorp (LH) on its strong segmental results in the fourth quarter of 2019.